Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05827081
Status:
SUSPENDED
Last Update Posted:
2024-04-24
First Post:
2023-04-12
Brief Title:
Phase IIIb Study of Ribociclib ET in Early Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2029-09-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-09-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-12
First Submit QC Date:
April 12 2023
Study First Post Date:
2023-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-24
Last Update Post Date Type:
ACTUAL